Propiedad y actividad de insiders de Organogenesis Holdings Inc. (ORGO): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.39 |
| Capitalización | $179M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $1.0M | $125886 | $21.3M | $60.2M | $84.4M | $113.9M | $102.5M | $104.3M | $135.6M | $93.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $34.1M | $39.4M | $56.8M | $82.5M | $89.5M | $82.0M | $109.9M | $217.5M |
| Inventario | 0 | 0 | $13.3M | $22.9M | $27.8M | $25.0M | $24.8M | $28.3M | $26.2M | $29.6M |
| Activos Corrientes | $1.4M | $294439 | $71.1M | $125.6M | $174.3M | $227.0M | $222.6M | $225.0M | $285.9M | $362.2M |
| Inmovilizado Material | 0 | 0 | $39.6M | $47.2M | $55.8M | $128.3M | $145.7M | $156.3M | $126.2M | $159.5M |
| Fondo de Comercio | 0 | 0 | $25.5M | $25.5M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M |
| Activos Intangibles | 0 | 0 | $26.1M | $20.8M | $30.6M | $25.7M | $20.8M | $15.9M | $12.5M | $9.1M |
| Activos Totales | $311.4M | $312.8M | $163.7M | $220.7M | $290.2M | $443.3M | $449.4M | $460.0M | $497.9M | $598.7M |
| Cuentas por Pagar | 0 | $19.1M | $19.2M | $28.4M | $23.4M | $29.3M | $32.3M | $30.7M | $28.9M | $31.9M |
| Deuda a Corto | 0 | $100000 | $2.5M | 0 | $16.7M | $2.7M | $4.5M | $5.5M | 0 | $18.6M |
| Pasivos Corrientes | $478360 | $3.9M | $66.4M | $59.9M | $68.2M | $82.7M | $75.0M | $80.5M | $77.5M | $100.1M |
| Deuda a Largo | 0 | 0 | $39.1M | $83.1M | $53.0M | $70.8M | $66.2M | $60.7M | 0 | $50.7M |
| Pasivos Totales | $11.3M | $14.8M | $116.6M | $165.1M | $148.4M | $201.9M | $183.7M | $181.4M | $112.6M | $164.8M |
| Reservas | -$233860 | -$2.3M | -$130.2M | -$171.0M | -$155.0M | -$60.8M | -$45.3M | -$41.0M | -$40.1M | -$3.1M |
| Patrimonio Neto | $300.1M | $298.0M | $47.0M | $55.6M | $141.8M | $241.3M | $265.7M | $278.7M | $385.3M | $433.9M |
| Deuda Total | 0 | $17.9M | $59.3M | $100.6M | $84.8M | $132.3M | $123.8M | $119.4M | $43.3M | $132.8M |
| Deuda Neta | -$1.0M | $17.7M | $38.0M | $40.4M | $377000 | $18.4M | $21.3M | $15.0M | -$92.3M | $39.2M |
| Capital Circulante | $957551 | -$3.6M | $4.7M | $65.7M | $106.1M | $144.3M | $147.6M | $144.5M | $208.5M | $262.1M |
Salud financiera
| Deuda / Patrimonio | 0.23 |
| Ratio corriente | 3.52 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 4.16 |
Rentabilidad
| Rentabilidad sobre capital | -24.23% |
| Rentabilidad sobre capital invertido | -8.12% |
| Rentabilidad sobre activos | -22.20% |
| Margen bruto | 67.59% |
| Margen operativo | -6.38% |
| Margen neto | -19.76% |
Empresas relacionadas: ANGO · BCYC · CMPX · EBS · EOLS · ESPR · MNPR
Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic
Más secciones de ORGO: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones